Commercial-stage pharmaceutical company
Appears in 1 story · Last updated Nov 8, 2026
In Chapter 11 and leaving Nasdaq; shares expected to trade over the counter as KPTIQ from November 11
Karyopharm Therapeutics filed for Chapter 11 on November 2, 2026, naming Ayrmid Ltd. as the lead bidder for its assets. A bankruptcy judge has approved bidding rules that set a December 16 deadline for competing offers, an auction on December 21 and a sale hearing on January 11, 2027.
Updated 4 days ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
